{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:10Z","timestamp":1786981270299,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-023-01533-9","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T03:04:09Z","timestamp":1679540649000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Conduction velocity is reduced in the posterior wall of hypertrophic cardiomyopathy patients with normal bipolar voltage undergoing ablation for paroxysmal atrial fibrillation"],"prefix":"10.1007","volume":"67","author":[{"given":"Sohail","family":"Zahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Tarabanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Barbhaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Knotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Chinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Jankelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"8","key":"1533_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","volume":"102","author":"BJ Maron","year":"2000","unstructured":"Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102(8):858\u201364.","journal-title":"Circulation"},{"issue":"21","key":"1533_CR2","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/hc4601.097997","volume":"104","author":"I Olivotto","year":"2001","unstructured":"Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517\u201324.","journal-title":"Circulation"},{"issue":"3","key":"1533_CR3","doi-asserted-by":"publisher","first-page":"e001002","DOI":"10.1161\/JAHA.114.001002","volume":"3","author":"KC Siontis","year":"2014","unstructured":"Siontis KC, Geske JB, Ong K, et al. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc. 2014;3(3):e001002.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"1533_CR4","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.4022\/jafib.1556","volume":"10","author":"M Patten","year":"2018","unstructured":"Patten M, Pecha S, Aydin A. Atrial fibrillation in hypertrophic cardiomyopathy: diagnosis and considerations for management. J Atr Fibrillation. 2018;10(5):1556.","journal-title":"J Atr Fibrillation"},{"issue":"5","key":"1533_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0735-1097(03)00855-6","volume":"42","author":"BJ Maron","year":"2003","unstructured":"Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003;42(5):882\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1533_CR6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","volume":"65","author":"BJ Maron","year":"2015","unstructured":"Maron BJ, Rowin EJ, Casey SA, et al. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. J Am Coll Cardiol. 2015;65(18):1915\u201328.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1533_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Haissaguerre","year":"1998","unstructured":"Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659\u201366.","journal-title":"N Engl J Med"},{"issue":"6","key":"1533_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho CY, Lopez B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363(6):552\u201363.","journal-title":"N Engl J Med"},{"issue":"6","key":"1533_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.hrcr.2021.03.017","volume":"7","author":"S Keane","year":"2021","unstructured":"Keane S, Fabre A, Keane D. Characterization of atrial histology in a patient with hypertrophic cardiomyopathy: Possible evidence of a primary atrial myopathy. HeartRhythm Case Rep. 2021;7(6):413\u20137.","journal-title":"HeartRhythm Case Rep"},{"issue":"8","key":"1533_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","volume":"51","author":"B Burstein","year":"2008","unstructured":"Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51(8):802\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1533_CR11","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.amjcard.2019.02.051","volume":"123","author":"CAS Miller","year":"2019","unstructured":"Miller CAS, Maron MS, Estes NAM III, et al. Safety, side effects and relative efficacy of medications for rhythm control of atrial fibrillation in hypertrophic cardiomyopathy. Am J Cardiol. 2019;123(11):1859\u201362.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1533_CR12","first-page":"210","volume":"2","author":"G Malasana","year":"2009","unstructured":"Malasana G, Day JD, Bunch TJ. Atrial fibrillation in hypertrophic obstructive cardiomyopathy - antiarrhythmics, ablation and more! J Atr Fibrillation. 2009;2(3):210.","journal-title":"J Atr Fibrillation"},{"issue":"3","key":"1533_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.hrthm.2005.11.013","volume":"3","author":"F Kilicaslan","year":"2006","unstructured":"Kilicaslan F, Verma A, Saad E, et al. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm. 2006;3(3):275\u201380.","journal-title":"Heart Rhythm"},{"issue":"6","key":"1533_CR14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/CIRCEP.113.000339","volume":"6","author":"P Santangeli","year":"2013","unstructured":"Santangeli P, Di Biase L, Themistoclakis S, et al. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence. Circ Arrhythm Electrophysiol. 2013;6(6):1089\u201394.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"1533_CR15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.amjcard.2006.12.087","volume":"99","author":"F Gaita","year":"2007","unstructured":"Gaita F, Di Donna P, Olivotto I, et al. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2007;99(11):1575\u201381.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1533_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/euq013","volume":"12","author":"P Di Donna","year":"2010","unstructured":"Di Donna P, Olivotto I, Delcre SD, et al. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace. 2010;12(3):347\u201355.","journal-title":"Europace"},{"issue":"19","key":"1533_CR17","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/heartjnl-2016-309406","volume":"102","author":"R Providencia","year":"2016","unstructured":"Providencia R, Elliott P, Patel K, et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart. 2016;102(19):1533\u201343.","journal-title":"Heart"},{"issue":"3","key":"1533_CR18","doi-asserted-by":"publisher","first-page":"e017451","DOI":"10.1161\/JAHA.120.017451","volume":"10","author":"L Dinshaw","year":"2021","unstructured":"Dinshaw L, Munkler P, Schaffer B, et al. Ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: treatment strategy, characteristics of consecutive atrial tachycardia and long-term outcome. J Am Heart Assoc. 2021;10(3):e017451.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1533_CR19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jce.13282","volume":"28","author":"SE Williams","year":"2017","unstructured":"Williams SE, Linton N, O\u2019Neill L, et al. The effect of activation rate on left atrial bipolar voltage in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28(9):1028\u201336.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1533_CR20","doi-asserted-by":"crossref","unstructured":"Shah CD, Everett THIV. Revisiting bipolar voltage mapping; Does the amplitude correlate to conduction velocity? Heart Rhythm.\u00a02023;20(3):438\u20139.","DOI":"10.1016\/j.hrthm.2022.11.023"},{"key":"1533_CR21","doi-asserted-by":"crossref","unstructured":"Ramirez FD, Meo M, Dallet C, et al. High-resolution mapping of reentrant atrial tachycardias: Relevance of low bipolar voltage. Heart Rhythm. 2023;20(3):430\u20137.","DOI":"10.1016\/j.hrthm.2022.11.003"},{"issue":"3","key":"1533_CR22","doi-asserted-by":"publisher","first-page":"e002897","DOI":"10.1161\/CIRCEP.115.002897","volume":"9","author":"K Fukumoto","year":"2016","unstructured":"Fukumoto K, Habibi M, Ipek EG, et al. Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2016;9(3):e002897.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"1533_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.hrthm.2018.10.029","volume":"16","author":"T Ustunkaya","year":"2019","unstructured":"Ustunkaya T, Desjardins B, Liu B, et al. Association of regional myocardial conduction velocity with the distribution of hypoattenuation on contrast-enhanced perfusion computed tomography in patients with postinfarct ventricular tachycardia. Heart Rhythm. 2019;16(4):588\u201394.","journal-title":"Heart Rhythm"},{"issue":"10","key":"1533_CR24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jacep.2019.06.017","volume":"5","author":"T Ustunkaya","year":"2019","unstructured":"Ustunkaya T, Desjardins B, Wedan R, et al. Epicardial conduction speed, electrogram abnormality, and computed tomography attenuation associations in arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2019;5(10):1158\u201367.","journal-title":"JACC Clin Electrophysiol"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"646023","DOI":"10.3389\/fphys.2021.646023","volume":"12","author":"SE Williams","year":"2021","unstructured":"Williams SE, Roney CH, Connolly A, et al. OpenEP: a cross-platform electroanatomic mapping data format and analysis platform for electrophysiology research. Front Physiol. 2021;12:646023.","journal-title":"Front Physiol"},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphys.2013.00154","volume":"4","author":"JH King","year":"2013","unstructured":"King JH, Huang CL, Fraser JA. Determinants of myocardial conduction velocity: implications for arrhythmogenesis. Front Physiol. 2013;4:154.","journal-title":"Front Physiol"},{"issue":"11","key":"1533_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O'Hanlon","year":"2010","unstructured":"O\u2019Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):867\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"1533_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jelectrocard.2021.06.001","volume":"69","author":"M Efremidis","year":"2021","unstructured":"Efremidis M, Bazoukis G, Vlachos K, et al. Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease. J Electrocardiol. 2021;69:87\u201392.","journal-title":"J Electrocardiol"},{"issue":"12","key":"1533_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1540-8167.2011.02125.x","volume":"22","author":"C Medi","year":"2011","unstructured":"Medi C, Kalman JM, Spence SJ, et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(12):1317\u201324.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1533_CR30","doi-asserted-by":"crossref","unstructured":"Lim WW, Neo M, Thanigaimani S, et al. Electrophysiological and structural remodeling of the atria in a mouse model of Troponin-I mutation linked hypertrophic cardiomyopathy: Implications for atrial fibrillation. Int J Mol Sci.\u00a02021;22(13).","DOI":"10.3390\/ijms22136941"},{"key":"1533_CR31","doi-asserted-by":"crossref","unstructured":"Wang L, Seidman JG, Seidman CE. Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann Intern Med. 2010;152(8):513\u201320, W181.","DOI":"10.7326\/0003-4819-152-8-201004200-00008"},{"issue":"12","key":"1533_CR32","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/pace.12227","volume":"36","author":"H Barajas-Martinez","year":"2013","unstructured":"Barajas-Martinez H, Hu D, Goodrow RJ Jr, Joyce F, Antzelevitch C. Electrophysiologic characteristics and pharmacologic response of human cardiomyocytes isolated from a patient with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2013;36(12):1512\u20135.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"9","key":"1533_CR33","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/cvr\/cvaa124","volume":"116","author":"R Coppini","year":"2020","unstructured":"Coppini R, Santini L, Olivotto I, Ackerman MJ, Cerbai E. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy. Cardiovasc Res. 2020;116(9):1585\u201399.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1533_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/cvr\/cvn274","volume":"81","author":"S Casini","year":"2009","unstructured":"Casini S, Verkerk AO, van Borren MM, et al. Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes. Cardiovasc Res. 2009;81(1):72\u201381.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"1533_CR35","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/europace\/euy095","volume":"20","author":"EM Benito","year":"2018","unstructured":"Benito EM, Cabanelas N, Nunez-Garcia M, et al. Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation. Europace. 2018;20(12):1959\u201365.","journal-title":"Europace"},{"issue":"7","key":"1533_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","volume":"57","author":"M Daccarett","year":"2011","unstructured":"Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1533_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1540-8167.2009.01515.x","volume":"20","author":"SS Po","year":"2009","unstructured":"Po SS, Nakagawa H, Jackman WM. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(10):1186\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"1533_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0008-6363(02)00226-2","volume":"54","author":"SY Ho","year":"2002","unstructured":"Ho SY, Anderson RH, Sanchez-Quintana D. Atrial structure and fibres: morphologic bases of atrial conduction. Cardiovasc Res. 2002;54(2):325\u201336.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1533_CR39","doi-asserted-by":"publisher","first-page":"e004133","DOI":"10.1161\/CIRCEP.116.004133","volume":"9","author":"F Pashakhanloo","year":"2016","unstructured":"Pashakhanloo F, Herzka DA, Ashikaga H, et al. Myofiber architecture of the human atria as revealed by submillimeter diffusion tensor imaging. Circ Arrhythm Electrophysiol. 2016;9(4):e004133.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"1533_CR40","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/jce.13321","volume":"28","author":"K Vlachos","year":"2017","unstructured":"Vlachos K, Efremidis M, Letsas KP, et al. Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28(12):1393\u2013402.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"14","key":"1533_CR41","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/0002-9149(92)90939-V","volume":"69","author":"P Spirito","year":"1992","unstructured":"Spirito P, Lakatos E, Maron BJ. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol. 1992;69(14):1217\u201322.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1533_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijcard.2013.11.002","volume":"170","author":"S Apostolakis","year":"2014","unstructured":"Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial. Int J Cardiol. 2014;170(3):303\u20138.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1533_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","volume":"7","author":"AM Shah","year":"2014","unstructured":"Shah AM, Claggett B, Sweitzer NK, et al. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail. 2014;7(5):740\u201351.","journal-title":"Circ Heart Fail"},{"issue":"22","key":"1533_CR44","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561\u20136.","journal-title":"N Engl J Med"},{"key":"1533_CR45","doi-asserted-by":"crossref","unstructured":"Han B, Trew ML, Zgierski-Johnston CM. Cardiac conduction velocity, remodeling and arrhythmogenesis. Cells.\u00a02021;10(11).","DOI":"10.3390\/cells10112923"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-023-01533-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T02:28:48Z","timestamp":1704421728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-023-01533-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1007\/s10840-023-01533-9","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was in accordance to the Helsinki ethical guidelines and approved by the NYU Langone Health IRB committee. The authors report no conflicts of interest with the material in this study. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}